Wednesday, October 17, 2007

FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With ... (Presseportal)

Philadelphia (ots/PRNewswire) - At the U.S. Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee meeting today, the majority of members voted to recommend the use of phosphate binders, including Shire ...

Read More...

[Source: Yahoo! News Search Results for liver disease help]

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)